
Benzinga Pro data, Albireo Pharma (NASDAQ:ALBO) reported Q4 sales of $32.52 million. Earnings fell to a loss of $10.96 million, resulting in a 119.2% decrease from last quarter. Albireo Pharma earned $57.09 million, and sales totaled $3.66 million in Q3.